mamasbabygirl Posted December 31, 2005 Share Posted December 31, 2005 OK, where to begin? Well, mom is now having brain surgery to remove the necrosis on January 9th. The pulmonologist explained the risks of anesthethia with us. She has never been under and her lung capacity is compromised. She was not eligible for HBO because of her diminished lung function, but surgery is doable apparently. The necrosis is causing a very poor quality of life for her. She is willing to take the risk and I support her in that decision. We have talked about how we're both afraid, but I feel postive about it. Sometimes I do, sometimes not. I have not found one single article online about removing radiation necrosis via surgery and that worries me. I do not want her to be a guinea pig. I need to ask the Doc lots of questions Tuesday at her pre-op appt. Any others? What is the expectation for her recovery? Timeframes, therapy, weaning from the ventilator. Should she stop Lovenox pre-surgery? Help me think!!! Right now, I am focusing on someone else's profile that says "When prayers go up, blessings come down." Love to all and a very happy new year to each and every one of us. Quote Link to comment Share on other sites More sharing options...
Nancy B Posted December 31, 2005 Share Posted December 31, 2005 LOri, sorry I can't be any help to you regarding questions, but I can sure pray. Nancy B Quote Link to comment Share on other sites More sharing options...
Miami Janet Posted December 31, 2005 Share Posted December 31, 2005 Hi Lori, I also have no experience with what your Mom is going to have done but will pray for your family. So sorry for all the rough times you all are having, hope you get some relief soon. I remember when my Mom was first diagnosed, the doctor said get ready as you will be on a real roller coaster ride. He was sure right and I never even liked rollercoasters..I was always scared of them. It was indeed a scary ride with highs and sudden drops that took my breath away. I know at times I just wanted off and I felt I couldnt do it anymore but just like you ...there isnt a choice.. You have to do your best for your Mom. Strength and courage to you Lori...Janet Quote Link to comment Share on other sites More sharing options...
sharyn Posted December 31, 2005 Share Posted December 31, 2005 Lori, I am sorry I have no answers about surgery. When Daddy was diagnosed with his brain tumor it too had "necrosis" so that made him unable to have gamma knife. I really never understood what necrosis was (do you?)nor di I ask. I think I was too burned out from the lung cancer and esphogus cancer that I just couldn't absorb anymore. I will be praying for you, for now, thats the best I have... Love, Sharon Quote Link to comment Share on other sites More sharing options...
hopeandstrength Posted December 31, 2005 Share Posted December 31, 2005 Just add me to the prayers and good thoughts for your mom group. I hope it goes well for her. Cathy Quote Link to comment Share on other sites More sharing options...
shineladysue Posted December 31, 2005 Share Posted December 31, 2005 Lori, Wish I had answers for you , but I have none. I just want you to know that you can count on my prayers. Love, Sue Quote Link to comment Share on other sites More sharing options...
kimmek Posted December 31, 2005 Share Posted December 31, 2005 Lori, I am so sorry to hear of this, I can only imagine how you must feel, but hold on and know you are in everyones thoughts and prayers. I know absolutly nothing about this nor have really heard of it, but I am home tonight nothing nothing, and I will search and see if there is anything I can learn and pass on to you. My heartfelt prayers to you and your Mom, Kim Quote Link to comment Share on other sites More sharing options...
karen335 Posted January 1, 2006 Share Posted January 1, 2006 Lori, Still trying to find info. for the necrosis surgery. We both need to know. That's why I haven't sent snything. Your mom is going to be fine, I feel it in my heart. As you read from another Profile... When prayers go up, Blessings come down. I believe that too.. Keeping you both in my prayers. God Bless and hugs, Karen Quote Link to comment Share on other sites More sharing options...
J.C. Posted January 1, 2006 Share Posted January 1, 2006 Lori, Sorry I have no answer for your questions, but I join in the prayers for your Mom. Hugs Jackie Quote Link to comment Share on other sites More sharing options...
Don M Posted January 1, 2006 Share Posted January 1, 2006 Lori: I can't find anything specific to removing necrotic tissue from the brain either. There is a lot of discussion on what it is and how it occurs. I suppose it would be better to have it removed though. I think brain sugery is not as risky as having a lung removed. I am sure the surgeon or the nurse will tell you about the lovenox. Before I had any surgery, I was always told not to take blood thinners. Just remember to ask about the lovenox. Your mom has my prayers. Don M Quote Link to comment Share on other sites More sharing options...
Linus32 Posted January 1, 2006 Share Posted January 1, 2006 Lori, I do not know the answers to your questions but I wanted to let you know you are in my prayers. Best of luck to your mom. Linus Quote Link to comment Share on other sites More sharing options...
Inkerdoodler Posted January 1, 2006 Share Posted January 1, 2006 Necrosis basically means "dead tissue" which happens when readiation kills tissue... I did a google search and found the following information (pretty clinical but it sounds like they want to remove it because it could cause further damage): Background: Radiation necrosis, a focal structural lesion that usually occurs at the original tumor site, is a potential long-term central nervous system (CNS) complication of radiotherapy or radiosurgery. Edema and the presence of tumor render the CNS parenchyma in the tumor bed more susceptible to radiation necrosis. Radiation necrosis can occur when radiotherapy is used to treat primary CNS tumors, metastatic disease, or head and neck malignancies. It can occur secondary to any form of radiotherapy modality or regimen. In the clinical situation of a recurrent astrocytoma (postradiation therapy), radiation necrosis presents a diagnostic dilemma. Astrocytic tumors can mutate to the more malignant glioblastoma multiforme. Glioblastoma multiforme's hallmark histology of pseudopalisading necrosis makes it difficult to differentiate radiation necrosis from recurrent astrocytoma using MRI. Therapeutic effects of radiotherapy: Radiation creates ionized oxygen species that react with cellular DNA. Tumor cells have less ability than healthy cells for DNA repair. Thus, between fractionation doses, healthy cells have a greater probability than tumor cells of repairing themselves. With each subsequent mitosis, the cumulative effects of unrepaired DNA result in apoptosis (cell death) of these tumor cells. Central nervous system syndromes secondary to radiotherapy: Radiation necrosis is part of a series of clinical syndromes related to CNS complications of radiotherapy. These syndromes occur in a distinct chronologic order and have characteristic pathophysiology. Acute encephalopathy occurs during and up to 1 month after radiotherapy. This acute encephalopathy is due to disruption of the blood-brain barrier. Early delayed complications occur 1-4 months after radiotherapy. Early delayed complications are caused by white matter injury characterized by demyelination and vasogenic edema. Early delayed changes may produce a somnolence syndrome in children, reappearance of the initial tumor's symptomatology, temporary decline in long-term memory, and encephalopathy. In early delayed complications, patients may have increased edema and contrast enhancement on MRI (both symptomatic and asymptomatic) that may resolve spontaneously over a few months. Both the acute and early delayed complications are steroid responsive. Radiation necrosis and diffuse cerebral atrophy are considered long-term complications of radiotherapy that occur from months to decades after radiation treatment. As opposed to the focal nature of radiation necrosis, diffuse cerebral atrophy is characterized by bihemispheric sulci enlargement, brain atrophy, and ventriculomegaly. Diffuse cerebral atrophy clinically is associated with cognitive decline, personality changes, and gait disturbances. Pathophysiology: Radiation necrosis is coagulative and predominantly affects white matter. This coagulative necrosis is due to small artery injury and thrombotic occlusion. These small arteries demonstrate endothelial thickening, lymphocytic and macrophagic infiltrates, presence of cytokines, hyalinization, fibrinoid deposition, thrombosis, and finally occlusion. Animals exposed to radiation and given antibodies to cytokines (tumor necrosis factor, interleukin-1, tissue growth factor) have decreased survival compared to animals that do not receive these antibodies. These cytokines may be involved in initially protecting healthy tissue from the effects of radiation. With prolonged radiation exposure, these particular cytokines are overexpressed and result in a cascade of inflammatory events and vascular injury. In addition to vessel occlusion with resultant tissue necrosis, telangiectatic vessels, which may hemorrhage, occasionally form. Demyelination, oligodendrocyte dropout, axonal swelling, reactive gliosis, and disruption of the blood-brain barrier also can be observed. Frequency: In the US: Natural history of the tumor in terms of prognosis and survival may affect the occurrence of radiation necrosis in a particular tumor population. In glioblastoma multiforme or metastatic disease with a poor long-term prognosis, the patient may not live long enough to develop radiation necrosis. Radiation necrosis can occur as soon as a few months or as long as decades after treatment. It generally occurs 6 months to 2 years after radiation therapy. Mortality/Morbidity: Radiation necrosis can be fatal. It also can cause problems associated with a mass lesion, such as seizures, focal deficits, increased intracranial pressure, and herniation syndromes. Sounds like removing it is good idea! Hope this information is of some help. Good luck - many prayers are with you! Sandy Quote Link to comment Share on other sites More sharing options...
Maryanne Posted January 1, 2006 Share Posted January 1, 2006 Hi Lori, Thinking about you and sending much prayers. I pray all comes out well with you mom. Maryanne Quote Link to comment Share on other sites More sharing options...
jdjenkins Posted January 1, 2006 Share Posted January 1, 2006 Sorry can't help with your questions. I will be praying for a sucessful surgery for your Mom on the 9th and strength for you to make it through all of this. I know how hard it is to take care of a sick parent and your own family. You are doing a great job! Denise Quote Link to comment Share on other sites More sharing options...
cindi o'h Posted January 1, 2006 Share Posted January 1, 2006 My knowledge is limited, but my heart is full of prayers for your mom, the surgeons, anesthesiologist, and you. love, Cindi Quote Link to comment Share on other sites More sharing options...
RandyW Posted January 1, 2006 Share Posted January 1, 2006 This might help if it works or copy into browser if it doesn't. Will saya prayer The initial approach to using radiation postoperatively to treat brain metastases, used to be whole brain radiation, but this was abandoned because of the substantial neurological deficits that resulted, sometimes appearing a considerable time after treatment. Whole brain radiation was routinely administered to patients after craniotomy for excision of a cerebral metastasis in an attempt to destroy any residual cancer cells at the surgical site. However, the deleterious effects of whole brain radiation, such as dementia and other irreversible neurotoxicities, became evident. This raised the question as to whether elective postoperative whole brain radiation should be administered to patients after excision of a solitary brain metastasis. Current clinical practice, at a number of leading cancer centers, use a more focused radiation field (Radiotherapy) that includes only 2-3cm beyond the periphery of the tumor site. This begins as soon as the surgical incision has healed. Many metastatic brain lesions are now being treated with stereotactic radiosurgery. In fact, some feel radiosurgery is the treatment of choice for most brain metastases. There are a number of radiation treatments for therapy (Stereotatic, Gamma-Knife, Cyber-Knife, Brachyradiation and IMRT to name a few). These treatments are focal and not diffuse. Unlike surgery, few lesions are inaccessible to radiosurgical treatment because of their location in the brain. Also, their generally small size and relative lack of invasion into adjacent brain tissue make brain metastases ideal candidates for radiosurgery. Multiple lesions may be treated as long as they are small. The risk of neurotoxicity from whole brain radiation is not insignificant and this approach is not indicated in patients with a solitary brain metastasis. Observation or focal radiation is a better choice in solitary metastasis patients. Whole brain radiation can induce neurological deterioration, dementia or both. Those at increased risk for long-term radiation effects are adults over 50 years of age. However, whole brain radiation therapy has been recognized to cause considerable permanent side effects mainly in patients over 60 years of age. The side effects from whole brain radiation therapy affect up to 90% of patients in this age group. Focal radiation to the local tumor bed has been applied to patients to avoid these complications. Aggressive treatment like surgical resection and focal radiation to the local tumor bed in patients with limited or no systemic disease can yield long-term survival. In such patients, delayed deleterious side effects of whole brain radiation therapy are particularly tragic. Within 6 months to 2 years patients can develop progressive dementia, ataxia and urinary incontinence, causing severe disability and in some, death. Delayed radiation injuries result in increased tissue pressure from edema, vascular injury leading to infarction, damage to endothelial cells and fibrinoid necrosis of small arteries and arterioles. Even the studies performed by Dr. Roy Patchell, et al, in the early and late 90's have been recognized incorrectly, sometimes, in the radiation oncology profession. The studies were thought to have been the difference between surgical excision of brain tumor alone vs. surgical excision & whole brain radiation. It was a study of whole brain radiation of a brain tumor alone vs. whole brain radiation & surgical excision. The increased success had been the surgery. And they measured "tumor recurrence", not "long-term survival". Patients experiencing any survival could have been dying from radiation necrosis, starting within two years of whole brain radiation treatment and documented as "complications of cancer" not "complications of treatment". There may have been less "tumor recurrence" but not more "long-term survival". Patchell's studies convincingly showed there was no survival benefit or prolonged independence in patients who received postoperative whole brain radiation therapy. The efficacy of postoperative radiotherapy after complete surgical resection had not been established. It never mentioned the incidence of dementia, alopecia, nausea, fatigue or any other numerous side effects associated with whole brain radiation. The most interesting part of this study were the patients who lived the longest. Patients in the observation group who avoided neurologic deaths had an improvement in survival, justifying the recommendation that whole brain radiation therapy is not indicated following surgical resection of a solitary brain metastasis. An editorial to Patchell's studies by Drs. Arlan Pinzer Mintz and J. Gregory Cairncross (JAMA 1998;280:1527-1529) described the morbidity associated with whole brain radiation and emphasized the importance of individualized treatment decisions and quality-of-life outcomes. The morbidity associated with whole brain radiation does not indicate whole brain radiation therapy following surgical resection of a solitary brain metastasis. Patients who avoided the neurologic side effects of whole brain radiation had an improvement in survival. There is no survival benefit or prolonged independence in patients who received postoperative whole brain radiation therapy. There may have been some less tumor recurrence but not more long-term survival. Had fatigue, memory loss and other adverse effects of whole brain radiation been considered, and had quality of life been measured, it might be less clear that whole brain radiation is the right choice for all patients. These patients do not remain functionally independent longer, nor do they live longer than those that have surgery alone, said researchers in a report in an issue of The Journal of the American Medical Association. Even M.D. Anderson Cancer Center, noted in their OncoLog, that whole brain radiation may still be the standard for "four or more" brain tumors, however, there are a variety of effective treatment modalities for people who have fewer than four tumors, and in particular for a solitary brain metastasis. The UCLA Metastatic Brain Tumor Program's goal is to treat metastatic disease "focally" so as to spare normal brain tissue and function. Focal treatment allows retreatment of local and new recurrences. This treatment delivers a single, large dose of radiation that is precisely targeted to the tumor and causes minimal damage to surrounding brain structures. The results of a recent study at the University of Pittsburgh School of Medicine reported that treating four or more brain tumors in a single radiosurgery session resulted in improved survival compared to whole brain radiation therapy alone. In the study, patients with primary malignancies that had metastasized to the brain underwent Gamma-Knife radiosurgery and the results indicated that treating four or more brain tumors with radiosurgery is safe and effective and translates into a survival benefit for patients. Sometimes, symptoms of brain damage appear many months or years after radiation therapy, a condition called late-delayed radiation damage (radiation necrosis or radiation encephalopathy). Radiation necrosis may result from the death of tumor cells and associated reaction in surrounding normal brain or may result from the necrosis of normal brain tissue surrounding the previously treated metastatic brain tumor. Such reactions tend to occur more frequently in larger lesions (either primary brain tumors or metastatic tumors). Radiation necrosis has been estimated to occur in 20% to 25% of patients treated for these tumors. Some studies say it can develop in at least 40% of patients irradiated for neoplasms following large volume or whole brain radiation and possibly 3% to 9% of patients irradiated focally for brain tumors that developed clinically detectable focal radiation necrosis. In the production of radiation necrosis, the dose and time over which it is given is important, however, the exact amounts that produce such damage cannot be stated. Late effects of whole brain radiation can include abnormalities of cognition (thinking ability) as well as abnormalities of hormone production. The hypothalamus is the part of the brain that controls pituitary function. The pituitary makes hormones that control production of sex hormones, thyroid hormone, cortisol. Both the pituitary and the hypothalamus will be irradiated if whole brain radiation occurs. Damage to these structures can cause disturbances of personality, libido, thirst, appetite, sleep and other symptoms as well. Psychiatric symptoms can be a prominent part of the clinical picture presented when radiation necrosis occurs. Again, whole brain radiation is the most damaging of all types of radiation treatments and causes the most severe side effects in the long run to patients. In the past, patients who were candidates for whole brain radiation were selected because they were thought to have limited survival times of less than 1-2 years and other technology did not exist. Today, many physicians question the use of whole brain radiation in most cases as one-session radiosurgery treatment can be repeated for original tumors or used for additional tumors with little or no side effects from radiation to healthy tissues. Increasingly, major studies and research have shown that the benefits of radiosurgery can be as effective as whole brain radiation without the side effects. Back to top gdpawel Senior User Joined: 15 Jan 2005 Posts: 105 Location: Pennsylvania Posted: Thu Nov 24, 2005 10:42 pm Post subject: Treating four or more brain tumors -------------------------------------------------------------------------------- Treating four or more brain tumors in a single radiosurgery session resulted in improved survival Medical Study News Published: Tuesday, October 18, 2005 Treating four or more brain tumors in a single radiosurgery session resulted in improved survival compared to whole brain radiation therapy alone, according to a study the University of Pittsburgh School of Medicine presented at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Denver. "Cancer patients with multiple metastases to the brain face very grim prognoses and limited treatment options," said John Flickinger, M.D., senior author of the study and professor of radiation oncology at the University of Pittsburgh School of Medicine. "In the past, these patients were not considered candidates for radiosurgery. The results of our study indicate that treating four or more brain tumors with radiosurgery is safe and effective and translates into a survival benefit for patients." Two hundred and five patients with primary malignancies that had metastasized to the brain underwent gamma knife radiosurgery for four or more tumors during one session. Gamma knife is a non-invasive, computer-driven, bloodless brain surgery that uses cobalt 60 to destroy tumors and vascular malformations and requires no surgical incisions. The average number of brain tumors for patients in the study was five, with a range from four to 18. Radiosurgery was used alone, in combination with whole brain radiation or after failure of whole brain radiation. Radiosurgery patients with the most prognostic factors associated with survival from brain metastases (defined as class 1 according to the Radiation Therapy Oncology Group classification system for patients with brain metastases) survived an average of 18 months, compared to a reported historical average of seven months for those who received whole brain radiation alone. Patients defined as class 2 who received radiosurgery survived nine months compared to the historical average survival of four months for patients who received whole brain radiation. Patients with the least prognostic factors associated with survival (class 3) who received radiosurgery survived an average of three months compared to the historical average survival of two months for patients who received whole brain radiation. The average overall survival for patients who received radiosurgery was eight months and the average time to progression and new brain metastases was nine months. "The study also found that the sum of the volume of all treated brain tumors was a more significant predictor of length of survival than was the total number of brain metastases, indicating that tumor volume should be used as a criterion for radiosurgery rather than number of brain metastases," added L. Dade Lunsford, M.D., Lars Leksell professor and chairman of the department of neurological surgery at the University of Pittsburgh School of Medicine. "Typically, only patients with one to three brain metastases are considered candidates for stereotactic radiosurgery," said Ajay K. Bhatnagar, M.D., study presenter and resident, department of radiation oncology, University of Pittsburgh School of Medicine. "However, based on the results from this study, we conclude that the number of brain metastases should not necessarily preclude patients with multiple lesions from this potentially life-saving treatment option." Also involved in the study from the University of Pittsburgh's departments of radiation oncology and neurological surgery was Douglas Kondziolka, M.D. Quote Link to comment Share on other sites More sharing options...
mamasbabygirl Posted January 2, 2006 Author Share Posted January 2, 2006 I think those two articles deal with remving the brain mets via surgery, not the necrosis. This is what I continually run into. Quote Link to comment Share on other sites More sharing options...
bunny Posted January 2, 2006 Share Posted January 2, 2006 Lori, I'm sure she'll have to stop the lovenox. other than that, I am useless to you, I am afraid, for anything other than prayers and support. xoxo amie Quote Link to comment Share on other sites More sharing options...
bethluvswill13 Posted January 3, 2006 Share Posted January 3, 2006 I'll be praying a lot for ya'll. I don't have answers only prayer. Hugs,Beth Quote Link to comment Share on other sites More sharing options...
MilliBr1 Posted January 3, 2006 Share Posted January 3, 2006 Lori, your mom is in my prayers. Quote Link to comment Share on other sites More sharing options...
Darci Posted January 3, 2006 Share Posted January 3, 2006 Lori, I don't have any medical help for you...just sending lots of support and prayers!! Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.